Roche Pharmaceutical Company Name On Labels Sto...
Roche Pharma enters ophthalmology segment
Pharma Careers for Doctors at Roche – Medic Foo...
Switzerland's Roche reports promising results f...
Roche | Pharma
Roche and Exelixis detail rare success for Cabo...
Roche enters obesity drug market with Carmot deal
New Cancer Immunotherapy Fails in First Roche T...
Roche Romania implements new distribution model...
Roche’s MS Drug Reports Promising Results - WSJ
EMA CHMP recommends approval for Roche’s therap...
After Failed Tests: Roche Pulls the Plug on Bre...
Roche Pharmaceuticals (division of Roche Group)...
Roche | Pharma Partnering Contact page
Roche - Pharma Journal
Roche Says Drug Meets Bladder Cancer Target - WSJ
Roche - Pharmaceutical Business review
Roche, Blueprint lung cancer drug wins FDA appr...
A history of Roche
Roche Holdings: Hold If You Have It, But Do Not...
Roche Sales Rise on Cancer Drugs - WSJ
Roche | Roche Pharma
Roche Revenue Lifted by Cancer and Immunology D...
Obesity drug from Roche shows promise in early ...
Roche begins new clinical trials of multiple sc...
Pharmaceutical Technology
Roche Fights Roche for $9 Billion Drug Business...
en
Roche | Our pharmaceuticals
Qui sommes-nous ? | Roche
Roche Announces $250M Deal to Acquire Good Ther...
Roche Pharmaceuticals – Element Data
Roche buys U.S. rights to Roivant bowel disease...
Roche scraps Alzheimer’s drug trials after fail...
FDA Approves Roche Immunotherapy for Bladder Ca...